BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 29155164)

  • 21. Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1.
    Dávola ME; Mazaira GI; Galigniana MD; Alché LE; Ramírez JA; Barquero AA
    Antiviral Res; 2015 Oct; 122():55-63. PubMed ID: 26259812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
    Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
    J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
    Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide inhibitors against herpes simplex virus infections.
    Galdiero S; Falanga A; Tarallo R; Russo L; Galdiero E; Cantisani M; Morelli G; Galdiero M
    J Pept Sci; 2013 Mar; 19(3):148-58. PubMed ID: 23389903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
    Levin MJ; Bacon TH; Leary JJ
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.
    Omura N; Fujii H; Yoshikawa T; Yamada S; Harada S; Inagaki T; Shibamura M; Takeyama H; Saijo M
    Virol J; 2017 Mar; 14(1):59. PubMed ID: 28320407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aciclovir resistance among Indian strains of Herpes simplex virus as determined using a dye uptake assay.
    Abraham AM; Kavitha S; Joseph P; George R; Pillay D; Malathi J; Jesudason MV; Sridharan G
    Indian J Med Microbiol; 2007 Jul; 25(3):260-2. PubMed ID: 17901647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial Pigment Prodigiosin Demonstrates a Unique Antiherpesvirus Activity That Is Mediated through Inhibition of Prosurvival Signal Transducers.
    Suryawanshi RK; Koujah L; Patil CD; Ames JM; Agelidis A; Yadavalli T; Patil SV; Shukla D
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses.
    Toscani A; Denaro R; Pacheco SFC; Biolatti M; Anselmi S; Dell'Oste V; Castagnolo D
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.
    Duan J; Liuzzi M; Paris W; Liard F; Browne A; Dansereau N; Simoneau B; Faucher AM; Cordingley MG
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1798-804. PubMed ID: 12760851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.
    Strand M; Islam K; Edlund K; Oberg CT; Allard A; Bergström T; Mei YF; Elofsson M; Wadell G
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5735-43. PubMed ID: 22908173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.
    Sanchez MD; Ochoa AC; Foster TP
    Antiviral Res; 2016 Aug; 132():13-25. PubMed ID: 27192555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice.
    Bhutta MS; Sausen DG; Reed KM; Gallo ES; Hair PS; Lassiter BP; Krishna NK; Cunnion KM; Borenstein R
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Herpes simplex virus resistance to antivirals].
    Burrel S; Topalis D; Boutolleau D
    Virologie (Montrouge); 2020 Oct; 24(5):325-342. PubMed ID: 33111706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New strategies against drug resistance to herpes simplex virus.
    Jiang YC; Feng H; Lin YC; Guo XR
    Int J Oral Sci; 2016 Mar; 8(1):1-6. PubMed ID: 27025259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mangiferin: A promising natural xanthone from Mangifera indica for the control of acyclovir - resistant herpes simplex virus 1 infection.
    Rechenchoski DZ; Agostinho KF; Faccin-Galhardi LC; Lonni AASG; da Silva JVH; de Andrade FG; Cunha AP; Ricardo NMPS; Nozawa C; Linhares REC
    Bioorg Med Chem; 2020 Feb; 28(4):115304. PubMed ID: 31956052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.